Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2022

Jun 18, 2022

31996_dirs_2022-06-17_e74b1770-0eb7-4b35-af99-516263cf6651.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2022-06-16

Reporting Person: Lin Elizabeth Yeu (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-06-16 Common Stock M 355 $0.00 Acquired 355 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-06-16 Common Stock Options $61.10 M 5765 Acquired 2032-06-15 Common Stock (5765) Direct

Footnotes

F1: On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock.

F2: The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to her continued service through the vesting date.